One acquisition solution for integrated services plus (OASIS+) unrestricted multiple agency contract (MAC)

Active Awarded Last action

Contract number
47QRCA25DU358
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 37% complete
IDV ceiling
$999,999,999,999.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition · 766 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The General Services Administration's Federal Acquisition Service awarded an indefinite-delivery contract to Acumen LLC (doing business as Medric) under the OASIS+ Unrestricted multiple-award government-wide acquisition contract on December 17, 2024, with a ceiling of $999,999,999,999.00 and an ultimate completion date of December 16, 2029. This is one of multiple awards under the OASIS+ Unrestricted program. The contract carries no set-aside.

Work is performed principally from Hillsborough and Burlingame, California. The originating solicitation, posted March 2, 2021, with a due date of March 29, 2023, sought management consulting and IT professional services under the government-wide vehicle.

Acumen LLC provides healthcare data analytics, research support, and technical assistance to federal health agencies. The company operates as a for-profit limited liability partnership in full-and-open competition across the Centers for Medicare and Medicaid Services, the Food and Drug Administration, the National Institutes of Health, the Centers for Disease Control and Prevention, and the Health Resources and Services Administration. Recent prime work includes a $77.3 million delivery order under the GSA Multiple Award Schedule for data analytics and technical assistance across CMS payment systems (September 30, 2026, through June 29, 2031); a $57.4 million CMS delivery order under the RMADA 2 IDIQ to implement and monitor the Transforming Episode Accountability Model (January 3, 2025, through January 2, 2033); and a $40.8 million FDA definitive contract for the Biologics Effectiveness and Safety post-market surveillance initiative (September 30, 2026, through September 29, 2029).

Transactions

Action Obligated Date
Other Administrative Action PA0003 $0
Other Administrative Action PO0003 $0
Other Administrative Action PSA913 $0
Other Administrative Action PSA910 $0
Supplemental Agreement for work within scope PSA908 $0
Other Administrative Action PA0002 $0
Other Administrative Action PA0001 $0
Other Administrative Action PSA898 $0
Other Administrative Action PSA891 $0
Original award $2,500

Quick answers

Who was awarded contract 47QRCA25DU358?

47QRCA25DU358 was awarded to Acumen LLC by Federal Acquisition Service (General Services Administration) on December 17, 2024.

How much is contract 47QRCA25DU358 worth?

47QRCA25DU358's own ceiling is $999,999,999,999.

Who can order from contract 47QRCA25DU358?

47QRCA25DU358 is a multiple award indefinite delivery contract. All agencies can place orders on it.

Is contract 47QRCA25DU358 part of a contract vehicle?

Yes. 47QRCA25DU358 is part of One Acquisition Solution for Integrated Services Plus - Unrestricted (OASIS+ Unrestricted).

Was contract 47QRCA25DU358 competed?

The extent of competition for 47QRCA25DU358 was full and open competition. The government received 766 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV